Skip to main content

Table 2 Characteristics of 21 patients who did not report a flare at the third and fourth follow-up visit

From: Serial magnetic resonance imaging and ultrasound examinations demonstrate differential inflammatory lesion patterns in soft tissue and bone upon patient-reported flares in rheumatoid arthritis

Characteristic

Follow-up visit 3

Follow-up visit 4

p value

DAS28CRP

2.2 (0.7)

2.2 (0.7)

0.59

CRP (mg/l)

5.2 (6.1)

5.1 (7,0)

0.82

SJC28

0.1 (0.4)

0.1 (0.4)

0.36

TJC28

1.5 (2.2)

1.5 (2.1)

0.64

EGA (VAS)

4.7 (4.3)

4.8 (3.6)

0.74

Pain (VAS)

16.2 (15.3)

15.7 (13.1)

0.76

PGA (VAS)

18.9 (17.5)

15.2 (16.3)

0.03

Patient-reported TJC28

1.0 (1.5)

1.0 (1.9)

0.80

Patient-reported SJC28

0.4 (1.1)

0.3 (0.7)

0.98

HAQ

0.4 (0.5)

0.4 (0.5)

0.22

RA-FQ

6.9 (5.3)

7.0 (6.6)

0.95

MRI synovitis

11.0 (3.5)

11.5 (3.6)

0.92

MRI tenosynovitis

6.6 (4.6)

6.8 (4.4)

0.46

MRI BME

3.3 (3.7)

3.3 (3.7)

0.19

GLOESS

9.1 (4.3)

9.4 (4.5)

0.08

US tenosynovitis

3.6 (4.5)

4.1 (5.1)

0.23

  1. Mean (SD) of clinical, patient-reported, and imaging characteristics. BME bone marrow edema, CRP C- reactive protein, DAS disease activity score, EGA evaluator global assessment, GLOESS Global OMERACT (Outcome Measures in Rheumatology) -EULAR (European League Against Rheumatism) Synovitis Score, HAQ health assessment questionnaire, MRI magnetic resonance imaging, PGA patient’s global assessment, RA-FQ OMERACT Rheumatoid Arthritis Flare Questionnaire, SJC28 swollen joint count in 28 joints, TJC28 tender joint count in 28 joints, US ultrasonography, VAS visual analog scale; p value for paired data comparison between visit 3 and visit 4 assessed by paired t test or Wilcoxon signed-rank test, as appropriate